Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Leukemia Clinical Trials

Protocol Number Title
1999LS060
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia
2001LS058
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2004LS006
MT2003-15 Use of Cyclophosphamide/Fludarabine to Promote in vivo Expansion of Donor Lymphocyte Infusions (DLI) to Enhance Efficacy after Allogeneic Transplant
2005LS036
MT2005-02 Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
2005LS043
MT2005-10 Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen
2005LS048
MT2004-24 Autologous Peripheral Blood Stem Cell Transplant for Patients with Lymphoma
2007LS022
MT2006-01 Phase I Study of Infusion of Umbilical Cord Blood (UCB) Derived CD25+ CD4+ T-Regulatory (Treg) Cells After Non-Myeloablative Cord Blood Transplantation
2007LS024
MT2006-24 Total Marrow Irradiation and Myeloablative Chemotherapy Followed by Double Umbilical Cord Blood Transplantation in Patients with Refractory Acute Leukemia
2007NT102
COG AALL05B1: A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Samples.
2009LS083
MT2009-15 Lymphodepleting Chemotherapy with Rituximab and Allogeneic Natural Killer Cells for Patients with Refractory Lymphoid Malignancies
2009NTLS116
MT2009-22R Monitoring of Immune Function and Minimal Residual Disease in Patients and Donors After Hematopoietic Cell Transplantation (HCT)
2009NTLS130
Hematologic Malignancy Tissue Bank Formerly: "Leukemia, Lymphoma and MDS Tissue Bank" Formerly: "Leukemia and MDS Tissue Bank" & "Pediatric Leukemia Tissue Bank"
2009NTUC056
Childhood Cancer Survivor Study
2010CG141
MT2010-22 CTN 0901: A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
2010LS030
HM2010-05 Phase I Open Label, Single Arm, Dose Escalation Trial to Evaluate the Biodistribution and Safety of AHN-12 In Patients with Advanced Leukemia
2010LS063
MT2010-10 Haploidentical Donor Natural Killer (NK) Cell Infusion with Intravenous Recombinant Human IL-15 (rhIL-15) in Adults with Refractory or Relapsed Acute Myelogenous Leukemia (AML)
2010LS086
MT2010-12: A First-in Humans,single-center,open-label, proof-of concept-study to evaluate the safety and tolerability of infusing HSC835 (LFU835-expanded Umbilical Cord hematopoietic stem Cells In patients with hematological malignancies
2010LSUC043
MT2010-06 KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
2010NTCG113
COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
2010UC121
MT2010-23R: Targeted Therapy for Bronchiolitis Obliterans Syndrome
2011CG134
COG AAML1031 - A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
2011CG135
COG ACCL0933 - A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
2011CG161
COG AALL1131 - A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND# 73789, NSC 606869) in the Very High Risk Stratum Add: AALL1131 Osteonecrosis Sub-study Per Case Reimbursement
2011IS127
MT2012-03: A Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Patients with High Risk Acute Myeloid Leukemia in First Complete Remission (CR1)
2011LS027
MT2011-05: Multi-Center Phase II Trial of NK Cell Based Non-Myeloablative Haploidentical Transplantation for Patients with High-Risk Acute Myeloid Diseases
2011LS158
HM2012-05: A Phase II Trial Investigating Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
2011NTLS026
HM2011-04R : Immune Profiling in Myelodysplastic Syndromes and Acute Myeloid Leukemia Myelodysplastic syndrome: Bench to Bedside
2011NTLS108
Impairments in Cognitive and Cerebral Vascular Function in Cancer Survivors - Development of Methods to Measure Cerebral Vascular Function in Survivors of Childhood Acute Lymphoblastic Leukemia
2012CG016
MT2012-01: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity(RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients with Hematologic Malignancies BMT CTN PROTOCOL 1101
2012CG099
COG ACCL1033 - A Comprehensive Approach to Improving Medication Compliance in Pediatric ALL
2012CG123
MT2013-05R: A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies
2012IS102
HM2012-18 Phase III, multicenter, randomized, trial of CPX-351 (Cytarabine:Daunorubicin) liposome injection versus Cytarabine and Daunorubicin in patients 60-75 years of age with untreated high risk (secondary) AML. (CLTR0310-301)
2012LS019
MT2012-06 Dose Escalation Study with Extension of Inducible Regulatory T Cells (iTregs) in Adult Patients Undergoing Non-Myeloablative HLA-Identical Sibling Donor Peripheral Blood Stem Cell Transplantation
2012LS023
HM2013-12 : IL-15 Agonists to Treat Relapse of Heme Malignancy after Allogeneic Transplantation
2012LS075
HM2013-16 A Phase 1 Study of DT2219ARL: A Bispecific SIngle Chain Immunotoxin for the Treatment of CD19+, CD22+ B-lineage Leukemia or Lymphoma
2012NTLS024
MT2012-24R Preparative Regimen Exposure-Response Relationships in Nonmyeloablative Stem Cell Transplants: Correlative Pharmacokinetics.
2012NTLS051
Pilot Study of Statin Therapy in Young Adult Survivors of Childhood Cancer
2012NTLS100
Treatment Effects in Children and Adolescent/Young Adults with Leukemia or Lymphoma.
2012OC065
MT2012-11C: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
2013CG079
COG ADVL1213 - A Phase 1 Study of the TEM-1 Antibody, MORAb-004 (IND#103821), in Children with Recurrent or Refractory Solid Tumors. Additional Title: ADVL1213 - Morphotek, Inc.
2013CG114
COG ADVL1114 - A Phase 1 Study of Temsirolimus (CCI779, IND#61010) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma
2013NTLS082
Family-based studies of myeloid disorders and related conditions
2013NTLS100
MT2013-28R : Positron Emission Tomography (PET) Imaging in Patients with High Risk Hematological Malignancies Receiving Total Body Irradiation (TBI) or Total Marrow Irradiation (TMI) as Part of a Hematopoietic Stem Cell Transplant
2013NTUC039
BMT Long-Term Follow-up Study -2
MT2006-13
MT2006-13 Autologous Peripheral Blood Stem Cell Transplant for Acute Non-Lymphocytic Leukemia (ANLL)

45 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on